March 30, 2016 |
There's a central dictum in engineering, in medicine, in life, at which Theranos, the controversial blood test company, has constantly failed. "In God we trust," the mid-century statistician William Edward Deming quipped. "All others bring data." Now, once again, Theranos does not have data to bring. But researchers at the Icahn School of Medicine at Mt. Sinai have done their own analysis of Theranos' tests.
Forbes